Drug Profile
Follitropin delta - Ferring Pharmaceuticals
Alternative Names: FE-999049; Recombinant follicle-stimulating hormone - Ferring Pharmaceuticals; Recombinant FSH - Ferring; RekovelleLatest Information Update: 02 Jan 2024
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Female infertility
- Preregistration Male infertility
Most Recent Events
- 02 Jan 2024 Preregistration for Female infertility in USA (SC), before January 2024 (Ferring Pharmaceuticals pipeline, January 2024).
- 02 Jan 2024 Preregistration for Male infertility in USA (SC), before January 2024 (Ferring Pharmaceuticals pipeline, January 2024).
- 21 Dec 2023 Ferring Pharmaceuticals completes the phase III trial in Female infertility in India (SC) (NCT04773353)